|
(b)(4).(b)(4).A manufacturing record evaluation was performed for the finished device qbmhsz batch number, and no non-conformances were identified.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent.-the patient demographic info: age, gender, weight, bmi at the time of index procedure -date of the index surgical procedure? -the diagnosis and indication for the index surgical procedure? -what was the onset date of necrosis following the index surgery? -did the patient experience an infection? -if yes, were cultures performed? results? -date the debridement and reapproximation were performed? -what was the appearance of the monocryl suture during the second procedure? -where and how was the dermabond device used (what layer of tissue and how many layers applied)? -was a dressing applied over the dermabond? if yes, please describe, including brand name -how many days post-op was the dressing in place? -what was the frequency of dressing changes? -has the patient had prior exposure to dermabond, prineo or skin adhesives? -lot number of dermabond used -other relevant patient history / concomitant medications? -if applicable, will product be returned? -what is the patient¿s current status? note: event related to topical skin adhesive reported via mw# 2210968-2020-07098.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|